Genoray Co. Ltd (122310) — Capital Reinvestment Ratio

Latest as of December 2025: 0.03x

Genoray Co. Ltd (122310) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩4.78 Billion) in capital expenditures (₩126.47 Million). See 122310 net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.78 Billion
KRW

Capital Expenditures

₩126.47 Million
KRW

Data as of

Dec 2025
Most recent filing

Genoray Co. Ltd Capital Reinvestment Ratio (2015–2025)

This chart tracks Genoray Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 122310 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Genoray Co. Ltd (2015–2025)

Year-by-year Capital Reinvestment Ratio for Genoray Co. Ltd from 2015 to 2025. For live market cap and broader valuation context, see Genoray Co. Ltd (122310) market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.27x ₩5.26 Billion ₩1.40 Billion ▼ -43.7%
2024 0.47x ₩13.27 Billion ₩6.29 Billion ▼ -80.4%
2023 2.42x ₩3.55 Billion ₩8.60 Billion ▲ +288.1%
2022 0.62x ₩14.84 Billion ₩9.25 Billion ▲ +79.7%
2021 0.35x ₩15.38 Billion ₩5.33 Billion ▲ +421.2%
2020 0.07x ₩8.51 Billion ₩566.06 Million ▼ -29.2%
2019 0.09x ₩10.65 Billion ₩1.00 Billion ▼ -53.2%
2018 0.20x ₩6.89 Billion ₩1.38 Billion ▲ +8.0%
2017 0.19x ₩4.47 Billion ₩830.19 Million ▼ -59.1%
2016 0.45x ₩3.47 Billion ₩1.58 Billion ▼ -60.2%
2015 1.14x ₩2.10 Billion ₩2.40 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow